Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells
Cameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay · 2024
Read Robust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells by Cameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642316.txt.
Description
Cameron Noah Keighron and co-authors compare two cell lines used to model Parkinson's disease in the lab. Their 2024 paper notes that aging populations raise the stakes for neurodegenerative research. The cell models used to develop therapies must be robust and repeatable, or the pipeline of new treatments rests on sand.
Both cell types carry dopamine-related traits. Exposed to two standard toxins, one line, LUHMES, reacted consistently, showing dopamine markers, energy loss, and oxidative stress. The other, SH-SY5Y, resisted both insults, raising doubts about how well it mimics the disease. Electrical tests found similar firing, but LUHMES answered calcium signals more strongly. The authors back LUHMES as the sturdier model.
Catalog record
| CREATOR | Cameron Noah Keighron, Sahar Avazzedeh, Leo R Quinlan, Yasemin M Akay |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |